Nuzenio

Odyssey Therapeutics

Odyssey Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 06:24:46 GMTOdyssey Therapeutics Ord Shs (Proposed) (ODTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 07 Aug 2026 17:24:18 GMTEvotec and Odyssey collaborate on AI-enabled R&D - pharmaceutical-business-review.com
Fri, 07 Aug 2026 16:52:36 GMTOdyssey Therapeutics (ODTX) Stock Forecast and Price Target 2026 - MarketBeat
Fri, 07 Aug 2026 16:50:31 GMTOdyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Fri, 07 Aug 2026 10:18:54 GMTEvotec and Odyssey Therapeutics enter AI-enabled drug discovery collaboration in autoimmune and inflammatory diseases - The Pharma Letter
Thu, 06 Aug 2026 22:42:48 GMTTop Odyssey Therapeutics (ODTX) Competitors 2026 - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Odyssey Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.